Composés apparentés aux enzymes, aux peptides et aux protéines

Clofibrate is a lipid-lowering agent that is used for the treatment of hyperlipidemia. It is a non-selective inhibitor of fatty acid synthesis and has been shown to inhibit cancer cell growth in vitro. Clofibrate inhibits tumor cell proliferation and induces apoptosis, which may be due to its ability to inhibit protein synthesis in cancer cells. This drug also suppresses the growth of breast cancer cells by inhibiting their ability to proliferate.

Garenoxacin mesylate hydrate is a quinolone antibiotic that suppresses the growth of bacteria by inhibiting DNA-dependent RNA polymerase in prokaryotes. It has been shown to be active against a wide range of bacterial strains. Garenoxacin mesylate hydrate has also been shown to have an antimicrobial effect in patients with infectious diseases or metabolic disorders, such as cervical cancer and autoimmune diseases. This drug binds to the bacterial ribosome and prevents protein synthesis, which leads to cell death. Garenoxacin mesylate hydrate has also been shown to have an antimicrobial effect in patients with infectious diseases or metabolic disorders, such as cervical cancer and autoimmune diseases. This drug binds to the bacterial ribosome and prevents protein synthesis, which leads to cell death.

Please enquire for more information about GLP-2 (1-33) (human) ammonium acetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about pTH (1-44) (human) including the price, delivery time and more detailed product information at the technical inquiry form on this page

Dextrorphan tartrate is a pharmaceutical drug that is used in the treatment of infections. It is taken by mouth and inhibits the uptake of fatty acids by liver cells, which then leads to the death of these cells. Dextrorphan tartrate has been shown to be active against viruses and experimental models of bacterial infection. It also has an effect on monoamine neurotransmitters, which may be responsible for its depressant effect on the central nervous system.

Potassium (phenylethynyl)trifluoroborate, also known as K(Phen)(ETBF), is a synthetic compound that is a potential anticancer agent. It was found to be cytotoxic to prostate cancer cells by inducing mitochondrial-dependent apoptosis and cell death. The mechanism of this process is still unknown, but it may involve the release of reactive oxygen species from mitochondria. K(Phen)(ETBF) has optical properties that enable it to be used in optical imaging techniques for cancer diagnosis. This compound has also been shown to have anticancer efficacy against various types of cancer cells in vitro and in vivo.

Please enquire for more information about Acetyl-PACAP-38 (human, mouse, ovine, porcine, rat) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

N-Cyano-N,N,N-Triethylammoniumtetrafluoroborate is a cationic ionic liquid that is immobilized on an anion exchange matrix. It has been optimized for use in chromatographic separation of proteins by molecular weight and size. N-Cyano-N,N,N-Triethylammoniumtetrafluoroborate has also been used to immobilize the recombinant human protein and to conjugate it with fluorescein. Optimization of the immobilization conditions was carried out by dialysis against water and lysine. This ionic liquid has a diameter of 8 nm, which ensures that it can be used for the separation of proteins by size.

2,4,6-Trihydroxybenzoic acid hydrate is a chemical compound that is used to treat inflammatory bowel disease. It has been shown to inhibit tumour necrosis factor-alpha (TNF-α) and cyclooxygenase-2 (COX-2), which are involved in the inflammatory process. In addition, 2,4,6-trihydroxybenzoic acid hydrate inhibits the growth of cancer cells by direct cytotoxicity or by blocking transcriptional regulation and the synthesis of proteins necessary for cellular proliferation. This drug also has antifungal activity against type strain; it is not active against Candida albicans. 2,4,6-Trihydroxybenzoic acid hydrate has been found to be effective in vitro as a wastewater treatment agent.

Chloromethyl isobutyrate (CMIB) is a reactive intermediate used in the production of acyclic nucleoside phosphonates. It has been shown to have significant antibacterial activity against Gram-positive bacteria and some Gram-negative bacteria. CMIB has been shown to be efficacious for the treatment of bowel diseases such as AIDS, hepatitis, and Crohn's disease. This drug is administered orally and it is metabolized via chemoenzymatic reactions in humans. The pharmacokinetic properties of CMIB are similar to those of other drugs that target the P2Y12 receptor.

Please enquire for more information about SILu™Prot CRP C-reactive protein human including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Cefepime dihydrochloride monohydrate impurity C including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about Neuropeptide Y (13-36), human including the price, delivery time and more detailed product information at the technical inquiry form on this page

Please enquire for more information about (Pyr 16)-VIP (16-28) (human, mouse, rat) including the price, delivery time and more detailed product information at the technical inquiry form on this page

5,6-Dimethyl-1H-benzotriazole hydrate is a heterogeneous catalyst that is used for the treatment of wastewater. It is prepared in situ by adding benzoic acid to 5,6-dimethylbenzotriazole and then reacting them with dry N2O4. The reaction mechanism involves the formation of an imine intermediate followed by the elimination of ammonia and water to give a benzotriazolium salt. The product is obtained as a white solid that can be purified using vacuum filtration or recrystallization. This heterogeneous catalyst has been shown to be effective in the analytical method for determining p-hydroxybenzoic acid in adipose tissue samples, urine samples, and homogeneous catalysts. It also produces nitrogen atoms as reaction products.

Ethyl isovalerate is a chemical with the formula CH3CH2CH2C(O)CH=CH2. It is an ester of acetic acid and valeric acid. It has a boiling point of 114°C and a density of 0.8994 g/mL at 20°C. Ethyl isovalerate has been shown to be thermally unstable, with significant expansion occurring when heated to 100°C. This chemical has been shown to have antibacterial properties against bacterial strains that are resistant to carvacrol, thymol, and cinnamaldehyde. Ethyl isovalerate also produces propionic acid when mixed with benzoic acid in liquid phase microextraction (LPME). The production of propionic acid may be due to the reaction between ethyl isovalerate and hydrogen fluoride on the surface of activated carbon particles in LPME. Ethyl decanoate can also be produced from this reaction by adding ethyl dec

2,6-Dimethyl-4-phenylpyronium tetrafluoroborate is a high quality reagent that is useful for the preparation of complex compounds. It is also a useful intermediate and building block. The CAS No. 97606-13-8, 2,6-Dimethyl-4-phenylpyronium tetrafluoroborate has been used in research chemicals and as a versatile building block for the synthesis of speciality chemicals. This reagent can be used in reactions to form many organic molecules that are not commercially available or difficult to synthesize.

Please enquire for more information about (Cys(Acm)2·7)-a-CGRP (human) trifluoroacetate salt including the price, delivery time and more detailed product information at the technical inquiry form on this page

N-[2-[Bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycine trisodium salt hydrate is a complexing agent that is used in the preparation of detergents and other surfactants. The compound has been shown to be highly efficient in the catalytic conversion of sodium citrate to citric acid, copper to copper sulfate, and hypophosphite to phosphorous acid. It has also been shown to have low ph, high density, and catalytic activity. N-[2-[Bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)glycine trisodium salt hydrate is stable over a wide range of temperatures (5-30 °C), pH values (4-10), and concentrations (0.1%-5%). The compound can also be used as an additive for the preparation of heterogeneous catalysts.

Procaterol is a bronchodilator that binds to the beta-2 adrenergic receptors on the smooth muscle in the bronchial tree. It stimulates these receptors, which causes bronchial dilation and an increase in airway flow. The drug has been shown to be effective for chronic cough, but not for acute cough. Procaterol is available as a rapid-acting oral formulation, as well as a slow-release form for once-daily administration. This drug has not been studied in children younger than 18 years of age. Procaterol HCl Hemihydrate is indicated for the treatment of obstructive airways disease, including chronic bronchitis and emphysema, and asthma. Procaterol is also used to treat or prevent bronchospasm in patients with reversible obstructive airways disease who are exposed to substances that can cause bronchospasm.